CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR
Company to complete and submit responses to FDA clinical hold Continues to study leronlimab in other HIV-related, NASH, and oncology indications Webcast...
Source: globenewswire.com
Compassionate Use Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Compassionate Use Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Compassionate Use Study Today - Breaking & Trending Today
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2022 Results - Earnings Call Transcript
TFF Pharmaceuticals, Inc. (NASDAQ:NASDAQ:TFFP) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO...
Source: seekingalpha.com
CytoDyn Inc. reveals 'very strong' updated results for cancer patients receiving its flagship drug leronlimab
A 12-month analysis of 28 metastatic triple-negative breast cancer patients receiving leronlimab suggests an increase of 3,600% in 12-month...
Source: proactiveinvestors.com
.jpg)
NA Proactive news snapshot: Australis Capital Inc, Vuzix Corporation, Infield Minerals Corp, Kootenay Silver Inc, Predictmedix Inc UPDATE ...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Source: proactiveinvestors.com